Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Silgan Hldgs
(NYSE:SLGN)
Intraday
$46.96
-0.06
[-0.13%]
After-Hours
$46.96
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$46.96
-0.06
[-0.13%]
At close: Apr 26
$46.96
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 5 days from now on Wed May 1st, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Silgan Hldgs Stock (NYSE:SLGN)
Silgan Hldgs Stock (NYSE: SLGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 11, 2024
Wells Fargo Maintains Overweight on Silgan Hldgs, Raises Price Target to $55
Benzinga Newsdesk
-
Apr 11, 2024, 10:43AM
Tuesday, February 27, 2024
Silgan Boosts Quarterly Cash Dividend By 5.6% From $0.18 To $0.19 Per Share
Benzinga Newsdesk
-
Feb 27, 2024, 5:02PM
Friday, February 02, 2024
Citigroup Maintains Neutral on Silgan Hldgs, Raises Price Target to $51
Benzinga Newsdesk
-
Feb 2, 2024, 2:15PM
Thursday, February 01, 2024
RBC Capital Maintains Outperform on Silgan Hldgs, Raises Price Target to $51
Benzinga Newsdesk
-
Feb 1, 2024, 11:17AM
Raymond James Maintains Outperform on Silgan Hldgs, Raises Price Target to $54
Benzinga Newsdesk
-
Feb 1, 2024, 9:41AM
JP Morgan Maintains Underweight on Silgan Hldgs, Raises Price Target to $46
Benzinga Newsdesk
-
Feb 1, 2024, 9:33AM
Wells Fargo Maintains Overweight on Silgan Hldgs, Raises Price Target to $52
Benzinga Newsdesk
-
Feb 1, 2024, 8:31AM
Wednesday, January 31, 2024
Why Silgan Holdings Shares Are Rising Today
Nabaparna Bhattacharya
-
Jan 31, 2024, 12:57PM
Silgan shares are trading higher after the company reported mixed Q4 financial results, issued guidance and announced a multi-year $50 million cost reduction program.
Benzinga Newsdesk
-
Jan 31, 2024, 10:12AM
Silgan Expects Q1 Adj. EPS Of $0.60-$0.70, Est. $0.72; FY24 Adj. EPS of $3.55-$3.75, Est. $3.61
Benzinga Newsdesk
-
Jan 31, 2024, 7:19AM
Silgan Reveals Multi-year $50M Cost Reduction Program
Benzinga Newsdesk
-
Jan 31, 2024, 6:58AM
Silgan Hldgs Q4 Adj EPS $0.63 Beats $0.58 Estimate, Sales $1.34B Miss $1.39B Estimate
Benzinga Newsdesk
-
Jan 31, 2024, 6:56AM
Earnings Scheduled For January 31, 2024
Benzinga Insights
-
Jan 31, 2024, 6:09AM
Tuesday, January 30, 2024
A Preview Of Silgan Hldgs's Earnings
Benzinga Insights
-
Jan 30, 2024, 2:01PM
Thursday, January 25, 2024
Raymond James Maintains Outperform on Silgan Hldgs, Raises Price Target to $52
Benzinga Newsdesk
-
Jan 25, 2024, 8:15AM
Thursday, January 04, 2024
Truist Securities Maintains Buy Rating for Silgan Hldgs: Here's What You Need To Know
Benzinga Insights
-
Jan 4, 2024, 12:00PM
Truist Securities Maintains Buy on Silgan Hldgs, Raises Price Target to $56
Benzinga Newsdesk
-
Jan 4, 2024, 11:07AM
Wednesday, January 03, 2024
Citigroup Downgrades Silgan Hldgs to Neutral, Raises Price Target to $47
Benzinga Newsdesk
-
Jan 3, 2024, 9:20AM
Friday, December 15, 2023
Wells Fargo Maintains Overweight on Silgan Hldgs, Raises Price Target to $50
Benzinga Newsdesk
-
Dec 15, 2023, 12:32PM
Tuesday, December 05, 2023
The Latest Analyst Ratings for Silgan Hldgs
Benzinga Insights
-
Dec 5, 2023, 10:00AM
Truist Securities Reiterates Buy on Silgan Hldgs, Maintains $52 Price Target
Benzinga Newsdesk
-
Dec 5, 2023, 9:44AM
Thursday, October 26, 2023
Truist Securities Maintains Buy on Silgan Hldgs, Lowers Price Target to $52
Benzinga Newsdesk
-
Oct 26, 2023, 2:24PM
RBC Capital Maintains Outperform on Silgan Hldgs, Lowers Price Target to $49
Benzinga Newsdesk
-
Oct 26, 2023, 1:43PM
Raymond James Maintains Outperform on Silgan Hldgs, Lowers Price Target to $49
Benzinga Newsdesk
-
Oct 26, 2023, 9:29AM
Wells Fargo Maintains Overweight on Silgan Hldgs, Lowers Price Target to $45
Benzinga Newsdesk
-
Oct 26, 2023, 8:58AM
Wednesday, October 25, 2023
Earnings Scheduled For October 25, 2023
Benzinga Insights
-
Oct 25, 2023, 7:32AM
Silgan Sees Q4 Adj. EPS of $0.55 to $0.65 Vs. Estimate Of $0.72
Benzinga Newsdesk
-
Oct 25, 2023, 7:01AM
Silgan Cuts FY23 Adj EPS Outlook To $3.30 to $3.40 From $3.40 - $3.60 Vs. $3.48 Est.
Benzinga Newsdesk
-
Oct 25, 2023, 6:59AM
Silgan Hldgs Q3 Adj. EPS $1.16 Beats $1.12 Estimate, Sales $1.80B Miss $1.95B Estimate
Benzinga Newsdesk
-
Oct 25, 2023, 6:57AM
Thursday, October 19, 2023
Expert Ratings for Silgan Hldgs
Benzinga Insights
-
Oct 19, 2023, 2:00PM
Wells Fargo Maintains Overweight on Silgan Hldgs, Lowers Price Target to $48
Benzinga Newsdesk
-
Oct 19, 2023, 9:42AM
Thursday, July 27, 2023
RBC Capital Maintains Outperform on Silgan Hldgs, Lowers Price Target to $51
Benzinga Newsdesk
-
Jul 27, 2023, 12:01PM
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Benzinga Insights
-
Jul 27, 2023, 11:00AM
JP Morgan Maintains Underweight on Silgan Hldgs, Lowers Price Target to $43
Benzinga Newsdesk
-
Jul 27, 2023, 10:41AM
Raymond James Maintains Outperform on Silgan Hldgs, Lowers Price Target to $50
Benzinga Newsdesk
-
Jul 27, 2023, 7:41AM
Baird Upgrades Silgan Hldgs to Outperform, Announces $53 Price Target
Benzinga Newsdesk
-
Jul 27, 2023, 5:08AM
Wednesday, July 26, 2023
Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jul 26, 2023, 1:57PM
Silgan Holdings shares are trading lower after the company reported worse-than-expected Q2 results and cut its FY23 outlook.
Bill Haddad
-
Jul 26, 2023, 1:31PM
Silgan Cuts FY23 Adj EPS Outlook From $3.95 - $4.15 To $3.40 - $3.60 Vs. $3.98 Est.
Benzinga Newsdesk
-
Jul 26, 2023, 6:59AM
Silgan Holdings Q2 Adj EPS $0.83 Misses $0.89 Estimate, Sales $1.43B Miss $1.55B Estimate
Benzinga Newsdesk
-
Jul 26, 2023, 6:56AM
Earnings Scheduled For July 26, 2023
Benzinga Insights
-
Jul 26, 2023, 4:18AM
Tuesday, July 25, 2023
Earnings Outlook For Silgan Holdings
Benzinga Insights
-
Jul 25, 2023, 1:01PM
Monday, July 17, 2023
The Latest Analyst Ratings for Silgan Hldgs
Benzinga Insights
-
Jul 17, 2023, 10:00AM
Wells Fargo Maintains Overweight on Silgan Hldgs, Lowers Price Target to $57
Benzinga Newsdesk
-
Jul 17, 2023, 9:04AM
Tuesday, July 11, 2023
Citigroup Maintains Buy on Silgan Hldgs, Lowers Price Target to $55
Benzinga Newsdesk
-
Jul 11, 2023, 10:56AM
Thursday, April 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2023
Benzinga Insights
-
Apr 27, 2023, 11:00AM
Raymond James Maintains Outperform on Silgan Hldgs, Lowers Price Target to $55
Benzinga Newsdesk
-
Apr 27, 2023, 7:18AM
Citigroup Upgrades Silgan Hldgs to Buy, Announces $56 Price Target
Benzinga Newsdesk
-
Apr 27, 2023, 6:34AM
Wednesday, April 26, 2023
Silgan shares are trading lower after the company reported worse-than-expected Q1 sales results and issued Q2 adjusted EPS guidance below analyst estimates.
Michael Horton
-
Apr 26, 2023, 10:14AM
Earnings Scheduled For April 26, 2023
Benzinga Insights
-
Apr 26, 2023, 7:13AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch